ANALISIS INTERAKSI OBAT PADA PASIEN DISPEPSIA DENGAN PENYAKIT PENYERTA DI INSTALASI RAWAT INAP DI RUMAH SAKIT X KABUPATEN MAJALENGKA TAHUN  2024

Authors

  • Tia Yulianti Universitas Muhammadiyah Ahmad Dahlan Cirebon
  • Ade Irawan Universitas Muhammadiyah Ahmad Dahlan Cirebon
  • Teguh Adiyas Putra Universitas Muhammadiyah Ahmad Dahlan Cirebon

DOI:

https://doi.org/10.36387/jifi.v8i2.2645

Keywords:

Dyspepsia, Drug Interaction, Comorbidities

Abstract

Dyspepsia is common digestive disorder that can significantly impact a patient's quality of life, particularly in individuals with comorbid conditions. Lifestyle factors, stress, and the use of various medications can contribute the onset of symptoms. One important aspect to consider is drug interactions, especially in elderly patients undergoing polypharmacy. This study aims to analyze drug usage patterns and identify potential drug interactions in patients diagnosed with dyspepsia and comorbidities. The research employed a non-experimental observational design using a retrospective descriptive method. Data were collected from inpatient medical records at Hospital X in Majalengka Regency, involving patients diagnosed with dyspepsia and accompanying illnesses. The profile dyspepsia patients with comorbidities in the inpatient unit of Majalengka Regional Hospital in 2024 was: the highest number patients were aged 46-55 years (24 patients, or 29%), and the highest number of patients were female (63 patients, or 78%). The most common single drug used for dyspepsia was ranitidine (14 cases, 87.50%). The most common two-drug combination was ranitidine and sucralfate (9 cases, 25.00%), and the most common three-drug combination was sucralfate + ranitidine + domperidone (12 cases, 37.50%). Drug interactions, based on severity, were classified as minor (32 cases, 96.97%), and moderate (1 case, 3.03%).

References

1. Zakiyah W, Eka Agustin A, Fauziah A, Sa’diyyah N, Ibnu Mukti G. Definisi, Penyebab, Klasifikasi, dan Terapi Sindrom Dispepsia. Jurnal Health Sains. 2021;2(7):978–85.

2. Purnamasari L. Faktor Risiko, Klasifikasi, dan Terapi Sindrom Dispepsia. Cermin Dunia Kedokteran. 2017;44(12):870–3.

3. Rasdianah N, Gani ASW. Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Dengan Penyakit Penyerta Di Rumah Sakit Otanaha Kota Gorontalo. Indonesian Journal of Pharmaceutical Education. 2021;1(1):40–6.

4. Ariska . et al 2023. Evaluasi Rasionalitas Penggunaan Obat Pada Pasien Dispepsia di Puskesmas Penawar Jaya. Jurnal Farmasi Malahayati. 2023;6(1):111–24.

5. Rahardiantini I, Sartika L. Pola Makan dan Karakteristik Mahasiswa Terhadap Gangguan Dispepsia Diet and Students Characteristics Againts Dyspepsia Disorders. Jurnal Keperawatan Stikes Hang Tuah Tanjungpinang. 2023;13(1):2023. Available from: https://doi.org/10.59870/jurkep.v12i1.121

6. Saragih DE, Arsita EV. The phytochemical content of Zanthoxylum acanthopodium and its potential as a medicinal plant in the regions of Toba Samosir and North Tapanuli, North Sumatra. Prosiding Seminar Nasional Masyarakat Biodiversitas Indonesia. 2019;5(1):71–6.

7. Habibie BY. Terapi pada Dispepsia. Jurnal Penelitian Perawat Profesional. 2021;3(3):503–10.

8. Nurhaidah FS, Anugrah SD, Putri AF, Tukloy WDR, Khairunnisa S, Primadani LH, et al. Pengetahuan Mahasiswa Universitas Airlangga Mengenai Dispepsia, Gastritis, Dan Gerd Beserta Antasida Sebagai Pengobatannya. Jurnal Farmasi Komunitas. 2021;8(2):57.

9. Rangka FM, Oktavia R, Novia J, Ningsih SW. Pola Peresepan Pasien Rawat Jalan Diagnosis Dispepsia di Rumah Sakit X Kabupaten Tangerang Prescription Pattern in Outpatient Dyspepsia in X Hospital Tangerang. 2021;30(2):75–81.

10. Begam RF, Ravikumar Y, Velmurugan R. Awareness about FDA announcement on voluntary recall of ranitidine among physicians and pharmacists in and around Chennai, India: a cross-sectional study. Future Journal of Pharmaceutical Sciences. 2021;7(1).

11. Barawa ATP, Saftarina F, Rahmanisa S, Graharti R. Kejadian Sindrom Dispepsia pada Perawat di RSUD Abdul Moeloek Bandar Lampung. Medula. 2019;8(2):27–32.

12. Rachmayanti AS, Suhera S, Haryani R, Sammulia SF, Meilandra R, Agnesfebrianti A. Gambaran Potensi Interakasi Obat pada Resep Polifarmasi Pasien Lansia di Rumah Sakit Badan Pengusahaan Batam. Jurnal Surya Medika. 2024;10(1):199–204.

13. Permadi YW, Riadi I, Rahmatullah S, Farmasi F, Dahlan UA, Industri FT, et al. Analisis Polifarmasi Terhadap Interaksi Obat Di Rumah Sakit Umum Kota Pekalongan. 2025;5(1):69–82.

14. Agustin OA, Fitrianingsih F. Kajian Interaksi Obat Berdasarkan Kategori Signifikansi Klinis Terhadap Pola Peresepan Pasien Rawat Jalan Di Apotek X Jambi. Electronic Journal Scientific of Environmental Health And Disease. 2021;1(1):1–10.

15. Mariam . et al 2022. Evaluasi Kejadian Interaksi Obat Antihipertensi Pada Pasien Rawat Jalan Di Puskesmas Tanah Sareal. Jurnal Farmamedika (Pharmamedica Journal). 2022;7(2):157–64.

Published

2025-12-31

How to Cite

1.
ANALISIS INTERAKSI OBAT PADA PASIEN DISPEPSIA DENGAN PENYAKIT PENYERTA DI INSTALASI RAWAT INAP DI RUMAH SAKIT X KABUPATEN MAJALENGKA TAHUN  2024. JIFI [Internet]. 2025 Dec. 31 [cited 2026 Aug. 25];8(2):273-84. Available from: https://e-jurnal.stikes-isfi.ac.id/index.php/JIFI/article/view/2645